The Food and Drug Administration approved a new device from Abbott meant to treat tricuspid heart valve disease — an expected decision after an outside advisory panel voted that the device’s benefits ...

People with tricuspid regurgitation (TR) are heavily reliant on care from their adult children and generally would like more and earlier education about their condition—these are the messages that ...

The Evoque transcatheter tricuspid valve replacement (TTVR) system continued to show significant benefits 1 year after implant, according to an update from the TRISCEND II trial. Among study ...

DUBLIN--(BUSINESS WIRE)--The "Tricuspid Valve Repair Market Size, Share & Trends Analysis Report By End-use (Ambulatory Surgical Centers, Hospitals), By Indication (Tricuspid Valve Regurgitation, ...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S.

Stopping leaks in the heart’s tricuspid valve has been a notoriously tricky fix, but, now, the FDA is handing out its second approval for a dedicated, minimally invasive therapy in as many months.

In a large clinical trial, the device was shown to reduce symptoms and hospitalization for heart failure for patients at high-risk for open-heart surgery. "This new procedure represents a significant ...

The American College of Cardiology and American Heart Association (ACC/AHA) have issued the first-ever performance and quality metrics for the treatment of patients with valvular and structural heart ...

IRVINE, Calif., Oct. 19, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced the company's EVOQUE tricuspid valve replacement system received CE Mark for the transcatheter ...

Valvular heart disease, also called heart valve disease, occurs when you have a diseased or damaged heart valve. When your heart pumps blood, your valves open and close to keep blood flowing in the ...

Mitral regurgitation (MR) and tricuspid regurgitation (TR) are two conditions involving backward leakage of blood through a heart valve when a ventricle contracts. People may experience either or both ...